Marker Discovery

Strategies and technologies for molecular phenotyping and biological marker discovery to improve understanding of disease and aid the pharmaceutical… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2016
02419972016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Whole-genome-shotgun (WGS) sequencing of total genomic DNA was used to recover ~1 Mbp of novel mitochondrial (mtDNA) sequence… (More)
Is this relevant?
2017
2017
High-throughput sequencing has laid the foundation for fast and cost-effective development of phylogenetic markers. Here we… (More)
Is this relevant?
2016
2016
BACKGROUND The freshwater mussel Cristaria plicata (Bivalvia: Eulamellibranchia: Unionidae), is an economically important species… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2016
2016
Title of Dissertation: DINOFLAGELLATE GENOMIC ORGANIZATION AND PHYLOGENETIC MARKER DISCOVERY UTILIZING DEEP SEQUENCING DATA… (More)
Is this relevant?
2013
2013
BACKGROUND Simple sequence repeats (SSRs) are ubiquitous in eukaryotic genomes. Chrysanthemum is one of the largest genera in the… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Conventional marker-based genotyping platforms are widely available, but not without their limitations. In this context, we… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
Amniotic fluid (AF) and amniotic membrane (AM) have been recently characterized as promising sources of stem or progenitor cells… (More)
  • figure 1
Is this relevant?
Review
2010
Review
2010
Our understanding of human disease and potential therapeutics is improving rapidly. In order to take advantage of these… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2003
Review
2003
During the last two decades, biomarker research has benefited from the introduction of new proteomic analytical techniques. In… (More)
Is this relevant?
1997
1997
  • Frank Lacombe
  • 1997
Executive Summary Exagen Diagnostics, Inc. uses computational technology to discover genomic markers that form the basis of… (More)
  • table 3
  • table 2
  • table 4
  • table 5
  • table 6
Is this relevant?